{"database": "lobbying", "table": "lobbying_activities", "rows": [[3046424, "58035e7b-0ff6-4978-a86b-4c9f31105ccc", "Q3", "COVINGTON & BURLING LLP", 11195, "HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.)", 2023, "third_quarter", "MMM", "Drug pricing policies, including The Safe Step Act.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-10-09T14:57:33-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3046424"], "units": {}, "query_ms": 14.395497040823102, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}